Drug
Buprenorphine And Naloxone
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Dental Caries | 36 | 56.6 | 58.3 | signal |
| 2 | Withdrawal Syndrome | 76 | 31.2 | 33.2 | signal |
| 3 | Tooth Fracture | 15 | 23.6 | 23.9 | signal |
| 4 | Product Substitution Issue | 78 | 23.5 | 25.0 | signal |
| 5 | Injection Site Reaction | 91 | 23.0 | 24.8 | signal |
| 6 | Tooth Loss | 25 | 20.7 | 21.2 | signal |
| 7 | Product Packaging Quantity Issue | 12 | 19.0 | 19.2 | signal |
| 8 | Cardio-respiratory Arrest | 42 | 17.3 | 17.9 | signal |
| 9 | Drug Abuse | 71 | 14.7 | 15.5 | signal |
| 10 | Drug Withdrawal Syndrome | 73 | 14.2 | 15.1 | signal |
| 11 | Drug Withdrawal Syndrome Neonatal | 12 | 13.9 | 14.0 | signal |
| 12 | Bipolar Disorder | 8 | 12.6 | 12.7 | signal |
| 13 | Serotonin Syndrome | 13 | 11.8 | 11.9 | signal |
| 14 | Restless Legs Syndrome | 12 | 11.4 | 11.5 | signal |
| 15 | Respiratory Depression | 8 | 11.3 | 11.4 | signal |
| 16 | Respiratory Arrest | 18 | 11.2 | 11.4 | signal |
| 17 | Oral Discomfort | 9 | 11.2 | 11.3 | signal |
| 18 | Therapy Change | 6 | 10.8 | 10.8 | signal |
| 19 | Incorrect Route Of Product Administration | 10 | 10.3 | 10.4 | signal |
| 20 | Euphoric Mood | 6 | 10.1 | 10.1 | signal |
| 21 | Renal Pain | 6 | 9.8 | 9.9 | signal |
| 22 | Poisoning | 7 | 9.6 | 9.7 | signal |
| 23 | Insurance Issue | 8 | 9.3 | 9.4 | signal |
| 24 | Product Taste Abnormal | 7 | 9.0 | 9.1 | signal |
| 25 | Product Dispensing Error | 11 | 8.8 | 8.8 | signal |
| 26 | Restlessness | 18 | 8.5 | 8.6 | signal |
| 27 | Tooth Extraction | 6 | 8.3 | 8.4 | signal |
| 28 | Product Physical Issue | 9 | 7.8 | 7.9 | signal |
| 29 | Product Prescribing Issue | 9 | 7.7 | 7.7 | signal |
| 30 | Toothache | 8 | 7.7 | 7.7 | signal |
| 31 | Premature Delivery | 7 | 7.6 | 7.6 | signal |
| 32 | Hyperhidrosis | 55 | 7.4 | 7.7 | signal |
| 33 | Libido Decreased | 5 | 7.0 | 7.0 | signal |
| 34 | Tooth Disorder | 9 | 7.0 | 7.0 | signal |
| 35 | Toxicity To Various Agents | 67 | 6.9 | 7.3 | signal |
| 36 | Cold Sweat | 7 | 6.9 | 6.9 | signal |
| 37 | Product Use Complaint | 6 | 6.7 | 6.7 | signal |
| 38 | Completed Suicide | 31 | 6.4 | 6.5 | signal |
| 39 | Apathy | 5 | 6.0 | 6.0 | signal |
| 40 | Mydriasis | 4 | 5.4 | 5.4 | signal |
| 41 | Poor Quality Product Administered | 3 | 5.1 | 5.1 | signal |
| 42 | Exposure During Pregnancy | 16 | 4.5 | 4.5 | signal |
| 43 | Drug Dependence | 40 | 4.3 | 4.4 | signal |
| 44 | Wrong Technique In Product Usage Process | 41 | 3.5 | 3.6 | signal |
| 45 | Product Quality Issue | 27 | 3.5 | 3.5 | signal |
| 46 | Foetal Exposure During Pregnancy | 16 | 3.4 | 3.4 | signal |
| 47 | Dystonia | 3 | 2.7 | 2.7 | no signal |
| 48 | Intentional Drug Misuse | 3 | 2.4 | 2.5 | no signal |
| 49 | Dependence | 4 | 1.2 | 1.2 | no signal |